Skip to content

Insider · CIK 0002014286

Deyaa Adib

officer

Files at KYNB (FIBROGEN INC). First filing Jun 13, 2024, latest Jun 13, 2024.

In brief

Deyaa Adib files SEC Form 4 as officer at KYNB (FIBROGEN INC). Since Jun 13, 2024, Deyaa Adib has reported 1 open-market buy worth $26k and 0 open-market sells worth $0, the latest filed on Jun 13, 2024.

A track record needs three past buys with six months of prices behind them; Deyaa Adib has 0, so none is measured yet.

The newest scored trade: bought $26k of KYNB on Jun 12, 2024, filed Jun 13, 2024, scored 34 (weak).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$26k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

KYNB: FIBROGEN INC

KYNBOct 12, 2026 · close 6.12

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
34Weak
KYNBbuy
FIBROGEN INC
$26k
22,123 shares
+37%+205% from low-93% from high

Transactions

Every row this insider has filed, 1 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 12, 2024KYNB
FIBROGEN INC
POpen-market purchase
Common Stock
+22,123$1.17$26k82,123Jun 13, 2024

Questions about Deyaa Adib

Answered from the filings on this page, as of the latest one.

Is Deyaa Adib buying or selling?

Not in the last 12 months. Deyaa Adib's latest open-market trade on SEC Form 4 was bought $26k of KYNB on Jun 12, 2024.

How did Deyaa Adib's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Deyaa Adib has 0.

Where does Deyaa Adib file Form 4?

Deyaa Adib has filed Form 4 at KYNB (FIBROGEN INC) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Deyaa Adib: insider trades and track record | InsiderTell